Endoscopic ultrasound-guided radiofrequency ablation for pancreatic cystic neoplasms: a comprehensive review - Takeaways - MDSpire

Endoscopic ultrasound-guided radiofrequency ablation for pancreatic cystic neoplasms: a comprehensive review

  • By

  • Xinzhu Sun

  • Nan Ge

  • June 15, 2026

  • 0 min

Share

  • 1

    Pancreatic cystic lesions (PCLs) are increasingly detected, with IPMN and MCN being notable for their malignant potential.

  • 2

    Current management of PCLs faces challenges, including imperfect risk stratification and the burden of long-term surveillance.

  • 3

    Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) is emerging as a minimally invasive treatment option for high-risk PCLs.

  • 4

    EUS-RFA combines precise targeting with thermal ablation, offering advantages over traditional surgical interventions.

  • 5

    The clinical value of EUS-RFA relies on further evidence-based data and standardization to establish its efficacy and safety.

Original Source(s)

Endoscopic ultrasound-guided radiofrequency ablation for pancreatic cystic neoplasms: a comprehensive review

  • by Xinzhu Sun, Nan Ge

  • June 15, 2026

Related Content

Revisiting gastric cancer disparities in Asian American subgroups: insights from the SEER database

Correction: Case Report: Quantitative and qualitative evaluation for electroacupuncture combined with moxibustion in the treatment of recalcitrant low anterior resection syndrome

Infliximab as ultima ratio in a case of refractory non-Crohn’s disease complex fistula system: case report and mini-review of the literature